Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 11;22(1):213.
doi: 10.1186/s12872-022-02654-1.

Association of serum sclerostin and osteoprotegerin levels with the presence, severity and prognosis in patients with acute myocardial infarction

Affiliations

Association of serum sclerostin and osteoprotegerin levels with the presence, severity and prognosis in patients with acute myocardial infarction

Xing Shui et al. BMC Cardiovasc Disord. .

Abstract

Background: Bone-related proteins (such as sclerostin and osteoprotegerin [OPG]) are involved in the development of atherosclerosis. However, the relationship between bone-related proteins and acute myocardial infarction (AMI) has not been extensively evaluated. The purpose of this study was to assess the association of serum sclerostin and OPG with the presence, severity and prognosis in patients with AMI.

Methods: This study prospectively enrolled 152 patients attacked by acute chest pain. Serum sclerostin and OPG were detected within the first 24 h after AMI diagnosis by ELISA kits. The AMI predictive efficacy of sclerostin and OPG were analyzed by receiver operating characteristics (ROC) curve. Univariable and multivariable linear regression analyses were performed to determine the association between bone-related proteins and scores indicating the severity of coronary artery occlusion. Moreover, prognostic values were assessed by Kaplan-Meier curves and Cox regression analysis.

Results: There were 92 patients in AMI group, 60 in non-AMI group. Serum levels of sclerostin and OPG were significantly higher in AMI group than in non-AMI group (all p < 0.001), which showed predictive value for the presence of AMI (all p < 0.001). The area under the ROC curve values of sclerostin and OPG were 0.744 and 0.897, respectively. A multivariable linear regression analysis demonstrated that Ln-transformed sclerostin (β = 0.288, p = 0.009) and Ln-transformed OPG (Ln-OPG: β = 0.295, p = 0.019) levels were associated with GENISINI score, independently of conventional clinical parameters. In addition, Ln-OPG levels were still positively associated with GRACE score after adjustments (β = 0.320, p = 0.001). During a 1-year follow-up, patients above the median of sclerostin levels had higher incidence of major adverse cardiac events (MACE) than those below the median (p = 0.028). It was also observed that the MACE rates were higher in patients above the median of OPG levels, though no statistic importance (p = 0.060). After adjusting conventional risk factors by multivariate Cox regression, Ln-OPG was associated with incident MACE (hazard ratio = 2.188 [95% confidence intervals 1.102-4.344], p = 0.025).

Conclusions: Bone-related proteins could exert a potential role in early risk stratification and prognosis assessment in patients with AMI.

Keywords: Acute myocardial infarction; Atherosclerosis; Osteoprotegerin; Prognosis; Sclerostin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
The predictive ability of serum bone-related proteins for AMI among patients with acute chest pain. a Predictive value. AMI: acute myocardial infarction, Scl: sclerostin, OPG: osteoprotegerin, cTNI: cardiac troponin I, AUC: area under the curve, CI: confidence intervals. b ROC curve. ROC: receiver operating characteristics. *p < 0.05 was considered statistically significant when compared with cTNI on admission
Fig. 2
Fig. 2
Correlation between serum bone-related proteins and scores indicating the severity of coronary artery occlusion. a Ln-sclerostin and GENSINI score b Ln-OPG and GENSINI score c Ln-sclerostin and GRACE score d Ln-OPG and GRACE score. Data of sclerostin and OPG showed skewed distribution and therefore were Ln-transformed before Pearson’s correlation analysis. GRACE: the global registry of acute coronary event, OPG: osteoprotegerin. p < 0.05 was considered statistically significant
Fig. 3
Fig. 3
Kaplan–Meier estimates of cumulative survival of AMI patients according to serum sclerostin levels (a), OPG levels (b), cTNI levels on admission (c) and peak values of cTNI after reperfusion (d). The continuous cTNI values on admission were transformed into the positive and the negative group based on the threshold values of 0.023 ng/mL. Bone-related proteins and the peak values of cTNI after reperfusion were divided into two groups: below and above the median group. (median sclerostin:526.31 pg/mL, median OPG:105.98 pg/mL, and median cTNI after reperfusion:25.07 ng/mL). AMI: acute myocardial infarction, OPG: osteoprotegerin, cTNI cardiac troponin I. p < 0.05 was considered statistically significant

Similar articles

Cited by

References

    1. Nielsen SH, Mouton AJ, DeLeon-Pennell KY, Genovese F, Karsdal M, Lindsey ML. Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes. Matrix Biol. 2019;75–76:43–57. doi: 10.1016/j.matbio.2017.12.001. - DOI - PMC - PubMed
    1. Muzyk P, Twerenbold R, Morawiec B, Ayala PL, Boeddinghaus J, Nestelberger T, et al. Use of cardiac troponin in the early diagnosis of acute myocardial infarction. Kardiol Pol. 2020;78(11):1099–1106. doi: 10.33963/KP.15585. - DOI - PubMed
    1. Kraus D, von Jeinsen B, Tzikas S, Palapies L, Zeller T, Bickel C, et al. Cardiac troponins for the diagnosis of acute myocardial infarction in chronic kidney disease. J Am Heart Assoc. 2018;7(19):e008032. doi: 10.1161/JAHA.117.008032. - DOI - PMC - PubMed
    1. Pourafkari L, Tajlil A, Nader ND. Biomarkers in diagnosing and treatment of acute heart failure. Biomark Med. 2019;13(14):1235–1249. doi: 10.2217/bmm-2019-0134. - DOI - PubMed
    1. Carmona-Fernandes D, Barreira SC, Leonardo N, Casimiro RI, Castro AM, Santos PO, et al. Atherosclerosis and bone loss in humans-results from deceased donors and from patients submitted to carotid endarterectomy. Front Med. 2021;8:672496. doi: 10.3389/fmed.2021.672496. - DOI - PMC - PubMed
  NODES
Association 6
twitter 2